Mary has over 20 years industrial experience within the large pharma sector (GSK and MedImmune) built across the drug discovery and development continuum through senior management roles in Research DMPK and as the global project leader for several development products.

Over the last five years, Mary has used her expertise in consulting for a diverse range of organisations from small pharmaceutical companies to academic spin-outs and charity backed drug discovery projects.